Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-206335) pertaining to the vTv Therapeutics Inc. 2015 Omnibus Equity Incentive Plan; |
|
(2) |
Registration Statement (Form S-3 No. 333-232571) of vTv Therapeutics Inc.; |
|
(3) |
Registration Statement (Form S-8 No. 333-240304) of vTv Therapeutics Inc.; |
|
(4) |
Registration Statement (Form S-1 No. 333-250934) of vTv Therapeutics Inc.; |
|
(6) |
Registration Statement (Form S-3 No. 333-256755) of vTv Therapeutics Inc. |
of our report dated March 29, 2022 with respect to the consolidated financial statements of vTv Therapeutics Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Raleigh, North Carolina
March 29, 2022